A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Chronic Drug-resistant Temporal Lobe Epilepsy - The SeLECT Study

Sodium selenate, 15mg three times a day, 26 weeks, oral tablet. Participants will be required to return unused tablets to site each visit to monitor compliance with dosing regimen.

硒酸钠，每日三次，每次15毫克，连续服用26周。受试者需在每次访问时将未使用的药片归还至研究地点，以监控其遵从给药方案的依从性。